Wednesday, May 22, 2024
28 C
Brunei Town

Britain approves AstraZeneca’s antibody-based COVID-19 therapy

CNA – Britain’s medicines regulator has approved AstraZeneca’s antibody-based COVID-19 treatment for adults with poor immune response, marking a major step in the fight against the pandemic as infections surge globally amid the spread of the Omicron variant. More details in Friday’s Borneo Bulletin.

spot_img

Latest

spot_img